Finance

Beta
Lists
AVTR:NYSE
Avantor Inc
$9.16
-3.78%
(-0.36) 1D
$9.16
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:09 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVTR...
Open
$9.53
High
$9.53
Low
$9.04
Mkt. cap
6.25B
Avg. vol.
10.28M
Volume
9.53M
52-wk high
$15.93
52-wk low
$7.26
EPS
-$0.81
Beta
0.97
Shares outstanding
682.76M
No. of employees
14K
Open
$9.53
High
$9.53
Low
$9.04
Mkt. cap
6.25B
Avg. vol.
10.28M
Volume
9.53M
52-wk high
$15.93
52-wk low
$7.26
EPS
-$0.81
Beta
0.97
Shares outstanding
682.76M
No. of employees
14K
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to AVTR in the past 3 months
Hold
Buy
0
Hold
7
Sell
2
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for AVTR in the last 3 months.
Highest
Current $9.16
$9.00 (-1.75%)
Average
$8.13 (-11.24%)
Lowest
$7.00 (-23.58%)
News stories
From sources across the web
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEOEmmanuel Ligner
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth care
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.17 / $0.16
+8.36%beat
Revenue / Est. (USD)
1.58B / 1.54B
+2.50%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.68B
1.62B
1.66B
1.58B
Cost of goods sold
1.13B
1.10B
1.14B
1.08B
Cost of revenue
1.13B
1.10B
1.14B
1.08B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
425.60M
388.80M
338.40M
401.70M
Operating expense
425.60M
388.80M
338.40M
401.70M
Total operating expenses
1.55B
1.49B
1.48B
1.48B
Operating income
128.50M
137.70M
185.50M
99.00M
Other non operating income
500.00K
700.00K
-7.00M
-
EBT including unusual items
81.70M
-689.50M
80.80M
55.50M
EBT excluding unusual items
81.70M
95.70M
136.40M
56.10M
Income tax expense
17.00M
22.30M
28.40M
12.20M
Effective tax rate
20.81%
-3.23%
35.15%
21.98%
Other operating expenses
-
-
-
-
Net income
64.70M
-711.80M
52.40M
43.30M
Net profit margin
3.84%
-43.84%
3.15%
2.74%
Earnings per share
0.24
0.22
0.22
0.17
Interest and investment income
11.00M
11.90M
11.40M
10.50M
Interest expense
-54.40M
-58.00M
-53.40M
-53.40M
Net interest expenses
-43.40M
-46.10M
-42.00M
-42.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
231.20M
242.20M
288.80M
204.00M
Gain or loss from assets sale
-
-
5.10M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more